Overview

  • Product name

    Human LOX1 ELISA Kit
    See all LOX 1 kits
  • Detection method

    Colorimetric
  • Precision

    Intra-assay
    Sample n Mean SD CV%
    Serum 8 8.6%
    Inter-assay
    Sample n Mean SD CV%
    Serum 3 10.5%
  • Sample type

    Cell culture supernatant, Serum, Cell culture extracts, Tissue Extracts, Heparin Plasma, EDTA Plasma, Citrate Plasma
  • Assay type

    Sandwich (quantitative)
  • Range

    15.625 pg/ml - 1000 pg/ml
  • Recovery

    Sample specific recovery
    Sample type Average % Range
    Cell culture supernatant 116 112% - 120%
    Serum 107 98% - 114%
    Cell culture extracts 98 97% - 99%
    Tissue Extracts 103 99% - 106%
    Heparin Plasma 105 104% - 106%
    EDTA Plasma 109 108% - 111%
    Citrate Plasma 105 99% - 113%

  • Assay time

    1h 30m
  • Assay duration

    One step assay
  • Species reactivity

    Reacts with: Human
    Does not react with: Mouse, Rat, Cow
  • Product overview

    LOX1 in vitro SimpleStep ELISA® (Enzyme-Linked Immunosorbent Assay) kit is designed for the quantitative measurement of LOX1 protein in human serum, plasma, cell culture supernatant, cell and tissue extract samples.


    The SimpleStep ELISA® employs an affinity tag labeled capture antibody and a reporter conjugated detector antibody which immunocapture the sample analyte in solution. This entire complex (capture antibody/analyte/detector antibody) is in turn immobilized via immunoaffinity of an anti-tag antibody coating the well. To perform the assay, samples or standards are added to the wells, followed by the antibody mix. After incubation, the wells are washed to remove unbound material. TMB substrate is added and during incubation is catalyzed by HRP, generating blue coloration. This reaction is then stopped by addition of Stop Solution completing any color change from blue to yellow. Signal is generated proportionally to the amount of bound analyte and the intensity is measured at 450 nm. Optionally, instead of the endpoint reading, development of TMB can be recorded kinetically at 600 nm.


    Sensitivity:


    Samples diluted in Sample Diluent NS: 6.85 pg/mL


    Samples diluted in 1X Cell Extraction Buffer PTR: 6.16 pg/mL

  • Notes

    LOX1 is a receptor expressed on several cell types which mediate a variety of cellular processes. On vascular endothelial cell, LOX1 is involved in the internalization and degradation of oxidatively modified low density lipoprotein (oxLDL). In addition to this role, it is a receptor for HSP70 protein and is a part of antigen cross presentation in dendritic cells to native T-cells. It is also a receptor f advanced glycation end products, activated platelets, monocytes, apoptotic cells and Gram-negative and Gram-positive bacteria.

  • Tested applications

    Suitable for: Sandwich ELISAmore details
  • Platform

    Pre-coated microplate (12 x 8 well strips)

Properties

  • Storage instructions

    Store at +4°C. Please refer to protocols.
  • Components 1 x 96 tests
    10X Human LOX1 Capture Antibody 1 x 600µl
    10X Human LOX1 Detector Antibody 1 x 600µl
    10X Wash Buffer PT (ab206977) 1 x 20ml
    50X Cell Extraction Enhancer Solution (ab193971) 1 x 1ml
    5X Cell Extraction Buffer PTR (ab193970) 1 x 10ml
    Antibody Diluent CPI 1 x 6ml
    Human LOX1 Lyophilized Recombinant Protein 2 vials
    Plate Seals 1 unit
    Sample Diluent NS 1 x 50ml
    SimpleStep Pre-Coated 96-Well Microplate (ab206978) 1 unit
    Stop Solution 1 x 12ml
    TMB Development Solution 1 x 12ml
  • Research areas

  • Function

    Receptor that mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells. OxLDL is a marker of atherosclerosis that induces vascular endothelial cell activation and dysfunction, resulting in pro-inflammatory responses, pro-oxidative conditions and apoptosis. Its association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. In addition to binding oxLDL, it acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. Also involved in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation. Also acts as a receptor for advanced glycation end (AGE) products, activated platelets, monocytes, apoptotic cells and both Gram-negative and Gram-positive bacteria.
  • Tissue specificity

    Expressed at high level in endothelial cells and vascular-rich organs such as placenta, lung, liver and brain, aortic intima, bone marrow, spinal cord and substantia nigra. Also expressed at the surface of dendritic cells. Widely expressed at intermediate and low level.
  • Involvement in disease

    Note=Independent association genetic studies have implicated OLR1 gene variants in myocardial infarction susceptibility.
    Note=OLR1 may be involved in Alzheimer disease (AD). Involvement in AD is however unclear: according to some authors (PubMed:12354387, PubMed:12810610 and PubMed:15976314), variations in OLR1 modify the risk of AD, while according to other (PubMed:15000751 and PubMed:15060104) they do not.
  • Sequence similarities

    Contains 1 C-type lectin domain.
  • Domain

    The cytoplasmic region is required for subcellular sorting on the cell surface.
    The C-type lectin domain mediates the recognition and binding of oxLDL.
  • Post-translational
    modifications

    The intrachain disulfide-bonds prevent N-glycosylation at some sites.
    N-glycosylated.
  • Cellular localization

    Cell membrane. Secreted. A secreted form also exists.
  • Information by UniProt
  • Alternative names

    • C-type lectin domain family 8 member A
    • CLEC8A
    • hLOX 1
    • hLOX-1
    • Lectin like oxidized LDL receptor 1
    • Lectin like oxLDL receptor 1
    • Lectin type oxidized LDL receptor 1
    • Lectin-like oxidized LDL receptor 1
    • Lectin-like oxLDL receptor 1
    • Lectin-type oxidized LDL receptor 1
    • low density lipoprotein oxidized, receptor 1
    • LOX-1
    • LOXIN
    • Olr1
    • OLR1_HUMAN
    • Ox LDL receptor 1
    • Ox-LDL receptor 1
    • Oxidised low density lipoprotein (lectin like) receptor 1
    • Oxidized low density lipoprotein receptor 1
    • Oxidized low density lipoprotein receptor 1 soluble form
    • Oxidized low-density lipoprotein receptor 1
    • OxLDL receptor 1
    • SCARE1
    • Scavenger receptor class E, member 1
    • SLOX1
    • soluble form
    • SR-EI
    see all
  • Database links

Associated products

Applications

Our Abpromise guarantee covers the use of ab212161 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Sandwich ELISA Use at an assay dependent concentration.

Images

  • SimpleStep ELISA technology allows the formation of the antibody-antigen complex in one single step, reducing assay time to 90 minutes. Add samples or standards and antibody mix to wells all at once, incubate, wash, and add your final substrate. See protocol for a detailed step-by-step guide.

     

  • Background-subtracted data values (mean +/- SD) are graphed.

  • Background-subtracted data values (mean +/- SD) are graphed.

  • The concentrations of LOX1 were measured in duplicates, interpolated from the LOX1 standard curves and corrected for sample dilution. Undiluted samples are as follows: serum 100%, plasma (citrate) 100%, plasma (heparin) 100% and plasma (EDTA) 100%. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean LOX1 concentration was determined to be 322 pg/mL in serum, 101 pg/mL in plasma (citrate), 106 pg/mL in plasma (heparin) and 165 pg/mL in plasma (EDTA).

  • The concentrations of LOX1 were measured in duplicate and interpolated from the LOX1 standard curve and corrected for sample dilution. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean LOX1 concentration was determined to be 927 pg/mL in Hela extract and 390 pg/mL in placenta extract.

  • Interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean LOX1 concentration was determined to be 211 pg/mL with a range of 83.5 – 745 pg/mL.

  • Interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean LOX1 concentration was determined to be 198 pg/mL with a range of 0 – 413 pg/mL.

Protocols

References

ab212161 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab212161.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up